APAC Antiviral Drugs Market - Industry Trends and Forecast to 2030
Asia-Pacific antiviral drugs market is expected to reach USD 15,118.64 million by 2030 from USD 9,004.35 million in 2022, growing with a CAGR of 6.7% during the forecast period from 2023 to 2030.
Market Segmentation:
Asia-Pacific Antiviral Drugs Market, By Indication (Influenza, Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Respiratory Syncytial Virus (RSV), Herpes Simplex Virus, Human Cytomegalovirus (HCMV), Varicella-Zoster Virus (VZV), Hepatitis B Virus (HBV), Coronavirus Infection, and Others), Patient Type (Child, Adult, and Geriatric), Products (Oral, Topical, and Parenteral), Drug Type (Generic and Branded), End User (Hospitals, Clinics, Home Healthcare, Specialty Centers, Ambulatory Centers, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), Country (China, Japan, India ,South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030.
Overview of Asia-Pacific Antiviral Drugs Market Dynamics:
Driver
• Rising prevalence of viral infections
Restrain
• High cost of antiviral drugs
Opportunity
• Increasing collaboration and partnership among key players
Market Players:
Some of the key market players operating in the Asia-Pacific antiviral drugs market are listed below:
• Gilead Sciences, Inc.
• F. Hoffmann-La Roche Ltd
• GLAXOSMITHKLINE PLC
• Abbvie
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Cipla Inc.
• Aurobindo Pharma
• Dr. Reddy’s Laboratories Ltd.
• Zydus Pharmaceuticals, Inc.
• Mylan Pharmaceuticals ULC
• Teva Pharmaceuticals USA, Inc.
• EMERGENT
• Sun Pharmaceutical Industries Ltd.
• Avet Pharmaceuticals Inc.
• Pfizer Inc.
• SIGA Technologies
• NAVINTA LLC.
• Macleods Pharmaceuticals Ltd.
• BioCryst Pharmaceuticals, Inc
• Hetero
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction 119
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Asia-pacific Antiviral Drugs Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation 127
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market Testing Type Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary 139
- 4 Premium Insights 142
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 5 Epidemiology 147
- 6 Pipeline Analysis For Asia-pacific Antiviral Drugs Market 148
- 7 Regulatory Framework 149
- 8 Market Overview 151
- 8.1 Drivers
- 8.1.1 Rising Prevalence Of Viral Infections
- 8.1.2 Advancements In New Antiviral Drug Development
- 8.1.3 Growing Demand For Combination Therapies
- 8.1.4 Increasing Government Funding And R&D Activities
- 8.2 Restrains
- 8.2.1 High Cost Of Antiviral Drugs
- 8.2.2 Emergence Of Drug-resistant Strains Of Viruses
- 8.3 Opportunities
- 8.3.1 Increasing Collaboration And Partnership Among Key Players
- 8.3.2 Rising Novel Drug Delivery Systems
- 8.3.3 Development Of Personalized Medicines
- 8.4 Challenges
- 8.4.1 Patent Expiration Of Antiviral Drugs
- 8.4.2 Demand For Alternative Medicines
- 9 Asia-pacific Antiviral Drugs Market, By Indication 161
- 9.1 Overview
- 9.2 Influenza
- 9.2.1 Neuraminidase Inhibitors
- 9.2.1.1 Oseltamivir
- 9.2.1.2 Zanamivir
- 9.2.1.3 Peramivir
- 9.2.1.4 Laninamivir
- 9.2.2 M2 Inhibitors
- 9.2.2.1 Rimantadine
- 9.2.2.2 Others
- 9.2.3 Rna Polymerase Inhibitors
- 9.2.3.1 Favipiravir
- 9.2.3.2 Baloxavir Marboxil
- 9.3 Human Immunodeficiency Virus (Hiv)
- 9.3.1 Reverse Transcriptase Inhibitors
- 9.3.1.1 Nucleoside (Nrtis)
- 9.3.1.1.1 Lamivudine
- 9.3.1.1.2 Abacavir
- 9.3.1.1.3 Didanosine
- 9.3.1.1.4 Others
- 9.3.1.2 Nonnucleoside (Nnrtis)
- 9.3.1.2.1 Efavirenz
- 9.3.1.2.2 Nevirapine
- 9.3.1.2.3 Delavirdine
- 9.3.1.2.4 Others
- 9.3.1.3 Integrase
- 9.3.1.3.1 Dolutegravir
- 9.3.1.3.2 Elvitegravir
- 9.3.1.3.3 Raltegravir
- 9.3.1.3.4 Bictegravir
- 9.3.1.4 Nucleotide
- 9.3.1.4.1 Tenofovir
- 9.3.1.4.2 Others
- 9.3.1.5 Interferons
- 9.3.1.5.1 Alpha
- 9.3.1.5.2 Beta
- 9.3.1.5.3 Gamma
- 9.3.1.6 Gp41
- 9.3.1.6.1 Enfuvirtide
- 9.3.1.6.2 Others
- 9.3.2 Protease
- 9.3.2.1 Atazanavir
- 9.3.2.2 Darunavir
- 9.3.2.3 Lopinavir
- 9.3.2.4 Ritonavir
- 9.3.2.5 Saquinavir
- 9.3.2.6 Indinavir
- 9.3.2.7 Nelfinavir
- 9.3.2.8 Tipranavir
- 9.3.2.9 Amprenavir
- 9.4 Hepatitis C Virus
- 9.4.1 Ns5b Polymerase
- 9.4.1.1 Sofosbuvir
- 9.4.1.2 Dasabuvir
- 9.4.2 Ns3/4a Protease
- 9.4.2.1 Danoprevir
- 9.4.2.2 Glecaprevir
- 9.4.2.3 Grazoprevir
- 9.4.2.4 Paritaprevir
- 9.4.2.5 Simeprevir
- 9.4.3 Ns5a Phosphoprotein
- 9.4.3.1 Ledipasvir
- 9.4.3.2 Velpatasvir
- 9.4.3.3 Ombitasvir
- 9.4.3.4 Elbasvir
- 9.4.3.5 Daclatasvir
- 9.4.3.6 Pibrentasvir
- 9.4.4 Neuraminidase
- 9.4.4.1 Oseltamivir
- 9.4.4.2 Zanamivir
- 9.4.4.3 Peramivir
- 9.4.4.4 Laninamivir
- 9.4.5 Rna Polymerase
- 9.4.5.1 Baloxavir Marboxil
- 9.4.5.2 Favipiravir
- 9.4.6 Matrix Protein 2
- 9.4.6.1 Rimatidine
- 9.4.6.2 Favipiravir
- 9.5 Herpes Simplex Virus
- 9.5.1 Dna Polymerase Ul30
- 9.5.1.1 Aciclovir
- 9.5.1.2 Famciclovir
- 9.5.1.3 Valaciclovir
- 9.5.1.4 Penciclovir Trifluridine
- 9.5.1.5 Brivudine
- 9.5.1.6 Foscarnet
- 9.5.1.7 Idoxuridine
- 9.5.2 Envelope Proteins
- 9.5.2.1 Docosanol
- 9.5.2.2 Others
- 9.6 Human Cytomegalovirus (Hcmv)
- 9.6.1 Ganciclovir
- 9.6.2 Valganciclovir
- 9.6.3 Cidofovir
- 9.6.4 Foscarnet
- 9.6.5 Fomivirsen
- 9.7 Varicella-zoster Virus (Vzv)
- 9.7.1 Valaciclovir
- 9.7.2 Famciclovir
- 9.7.3 Aciclovir
- 9.7.4 Vidarabine
- 9.7.5 Brivudine
- 9.8 Hepatitis B Virus
- 9.8.1 Entecavir
- 9.8.2 Tenofovir
- 9.8.3 Telbivudine
- 9.8.4 Tenofovir Alafenamide
- 9.8.5 Others
- 9.9 Respiratory Syncytial Virus
- 9.9.1 Rna Polymerase
- 9.9.1.1 Ribavirin
- 9.9.1.2 Others
- 9.9.2 Fusion Glycoprotein
- 9.9.2.1 Palivizumab
- 9.9.2.2 Others
- 9.10 Coronavirus Infection
- 9.11 Others
- 10 Asia-pacific Antiviral Drugs Market, By Patient Type 192
- 10.1 Overview
- 10.2 Geriatric
- 10.2.1 Male
- 10.2.2 Female
- 10.3 Child
- 10.3.1 Male
- 10.3.2 Female
- 10.4 Adult
- 10.4.1 Male
- 10.4.2 Female
- 11 Asia-pacific Antiviral Drugs Market, By Products 200
- 11.1 Overview
- 11.2 Oral
- 11.2.1 Solid
- 11.2.1.1 Tablets
- 11.2.1.2 Capsules
- 11.2.1.3 Others
- 11.2.2 Semisolid
- 11.2.2.1 Gels
- 11.2.2.2 Emulsions
- 11.2.2.3 Elixirs
- 11.2.2.4 Others
- 11.2.3 Liquid
- 11.2.3.1 Solutions
- 11.2.3.2 Syrups
- 11.2.3.3 Others
- 11.3 Topical
- 11.3.1 Semi-solid
- 11.3.1.1 Cream
- 11.3.1.2 Ointment
- 11.3.1.3 Gels
- 11.3.1.4 Others
- 11.3.2 Liquid
- 11.3.2.1 Solutions
- 11.3.2.2 Suspensions
- 11.3.3 Solid
- 11.3.3.1 Powders
- 11.3.3.2 Suppositories
- 11.3.3.3 Enema
- 11.3.3.4 Others
- 11.4 Parenteral
- 11.4.1 Conventional Drug Delivery Formualtions
- 11.4.1.1 Solutions
- 11.4.1.2 Reconstituted/Lyophilized
- 11.4.1.3 Suspensions
- 11.4.1.4 Emulsions
- 11.4.1.5 Others
- 11.4.2 Novel Drug Delivery Formulations
- 11.4.3 Colloidal Dispersions
- 11.4.4 Long Acting Injection Formulation
- 12 Asia-pacific Antiviral Drugs Market, By Drug Type 213
- 12.1 Overview
- 12.2 Generic
- 12.3 Branded
- 13 Asia-pacific Antiviral Drugs Market, By End User 218
- 13.1 Overview
- 13.2 Hospital
- 13.3 Specialty Centers
- 13.4 Ambulatory Centres
- 13.5 Clinics
- 13.6 Home Healthcare
- 13.7 Others
- 14 Asia-pacific Antiviral Drugs Market, By Distribution Channel 225
- 14.1 Overview
- 14.2 Hospital Pharmacy
- 14.3 Retail Pharmacy
- 14.4 Online Pharmacy
- 15 Asia-pacific Antiviral Drugs Market, By Region 231
- 15.1 Asia-pacific
- 15.1.1 Japan
- 15.1.2 China
- 15.1.3 South Korea
- 15.1.4 India
- 15.1.5 Australia
- 15.1.6 Singapore
- 15.1.7 Thailand
- 15.1.8 Malaysia
- 15.1.9 Indonesia
- 15.1.10 Philippines
- 15.1.11 Vietnam
- 15.1.12 Rest Of Asia-pacific
- 16 Asia-pacific Antiviral Drugs Market: Company Landscape 445
- 16.1 Company Share Analysis: Asia-pacific
- 17 Swot Analysis 446
- List Of Tables
- Table 1 Asia-pacific Antiviral Drugs Market, By Indication, 2021-2030 (Usd Million)
- Table 2 Asia-pacific Influenza In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 3 Asia-pacific Influenza In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 4 Asia-pacific Neuraminidase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 5 Asia-pacific M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 6 Asia-pacific M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 7 Asia-pacific Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 8 Asia-pacific Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 9 Asia-pacific Reverse Transcriptase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 10 Asia-pacific Nucleoside (Nrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 11 Asia-pacific Nonnucleoside (Nnrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 12 Asia-pacific Integrase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 13 Asia-pacific Nucleotide In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 14 Asia-pacific Interferons In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 15 Asia-pacific Gp41 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 16 Asia-pacific Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 17 Asia-pacific Hepatitis C Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 18 Asia-pacific Hepatitis C Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 19 Asia-pacific Ns5b Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 20 Asia-pacific Ns3/4a Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 21 Asia-pacific Ns5a Phosphoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 22 Asia-pacific Neuraminidase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 23 Asia-pacific Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 24 Asia-pacific Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 25 Asia-pacific Herpes Simplex Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 26 Asia-pacific Herpes Simplex Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 27 Asia-pacific Dna Polymerase Ul30 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 28 Asia-pacific Envelope Proteins In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 29 Asia-pacific Human Cytomegalovirus (Hcmv) In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 30 Asia-pacific Human Cytomegalovirus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 31 Asia-pacific Varicella-zoster Virus (Vzv) In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 32 Asia-pacific Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 33 Asia-pacific Hepatitis B Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 34 Asia-pacific Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 35 Asia-pacific Respiratory Syncytial Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 36 Asia-pacific Respiratory Syncytical Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 37 Asia-pacific Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 38 Asia-pacific Fusion Glycoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 39 Asia-pacific Coronavirus Infection In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 40 Asia-pacific Others In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 41 Asia-pacific Antiviral Drugs Market, By Patient Type, 2021- 2030 (Usd Million)
- Table 42 Asia-pacific Geriatric In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 43 Asia-pacific Geriatric In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 44 Asia-pacific Child In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 45 Asia-pacific Child In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 46 Asia-pacific Adult In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 47 Asia-pacific Adult In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 48 Asia-pacific Antiviral Drugs Market, By Product, 2021- 2030 (Usd Million)
- Table 49 Asia-pacific Oral In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 50 Asia-pacific Oral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 51 Asia-pacific Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 52 Asia-pacific Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 53 Asia-pacific Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 54 Asia-pacific Topical In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 55 Asia-pacific Topical In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 56 Asia-pacific Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 57 Asia-pacific Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 58 Asia-pacific Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 59 Asia-pacific Parenteral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 60 Asia-pacific Parenteral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 61 Asia-pacific Conventional Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 62 Asia-pacific Novel Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 63 Asia-pacific Antiviral Drugs Market, By Drug Type, 2021- 2030 (Usd Million)
- Table 64 Asia-pacific Antiviral Drugs Market, By End User, 2021- 2030 (Usd Million)
- Table 65 Asia-pacific Antiviral Drugs Market, By Distribution Channel, 2021- 2030 (Usd Million)
- Table 66 Asia-pacific Antiviral Drugs Market, By Country, 2021-2030 (Usd Million)
- Table 67 Asia-pacific Antiviral Drugs Market, By Indication, 2021-2030 (Usd Million)
- Table 68 Asia-pacific Influenza In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 69 Asia-pacific Neuraminidase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 70 Asia-pacific M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 71 Asia-pacific Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 72 Asia-pacific Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 73 Asia-pacific Reverse Transcriptase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 74 Asia-pacific Nucleoside (Nrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 75 Asia-pacific Nonnucleoside (Nnrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 76 Asia-pacific Integrase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 77 Asia-pacific Nucleotide In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 78 Asia-pacific Interferons In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 79 Asia-pacific Gp41 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 80 Asia-pacific Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 81 Asia-pacific Hepatitis C Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 82 Asia-pacific Ns5b Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 83 Asia-pacific Ns3/4a Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 84 Asia-pacific Ns5a Phosphoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 85 Asia-pacific Neuraminidase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 86 Asia-pacific Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 87 Asia-pacific Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 88 Asia-pacific Herpes Simplex Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 89 Asia-pacific Dna Polymerase Ul30 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 90 Asia-pacific Envelope Proteins In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 91 Asia-pacific Human Cytomegalovirus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 92 Asia-pacific Varicella-zoster Virus (Vzv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 93 Asia-pacific Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 94 Asia-pacific Respiratory Syncytical Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 95 Asia-pacific Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 96 Asia-pacific Fusion Glycoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 97 Asia-pacific Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 98 Asia-pacific Geriatric In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 99 Asia-pacific Child In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 100 Asia-pacific Adult In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 101 Asia-pacific Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 102 Asia-pacific Oral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 103 Asia-pacific Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 104 Asia-pacific Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 105 Asia-pacific Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 106 Asia-pacific Topical In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 107 Asia-pacific Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 108 Asia-pacific Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 109 Asia-pacific Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 110 Asia-pacific Parenteral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 111 Asia-pacific Conventional Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 112 Asia-pacific Novel Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 113 Asia-pacific Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 114 Japan Antiviral Drugs Market, By Indication, 2021-2030 (Usd Million)
- Table 115 Japan Influenza In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 116 Japan Neuraminidase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 117 Japan M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 118 Japan Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 119 Japan Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 120 Japan Reverse Transcriptase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 121 Japan Nucleoside (Nrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 122 Japan Nonnucleoside (Nnrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 123 Japan Integrase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 124 Japan Nucleotide In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 125 Japan Interferons In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 126 Japan Gp41 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 127 Japan Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 128 Japan Hepatitis C Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 129 Japan Ns5b Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 130 Japan Ns3/4a Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 131 Japan Ns5a Phosphoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 132 Japan Neuraminidase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 133 Japan Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 134 Japan Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 135 Japan Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 136 Japan Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 137 Japan Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 138 Japan Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 139 Japan Envelope Proteins In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 140 Japan Human Cytomegalovirus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 141 Japan Varicella-zoster Virus (Vzv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 142 Japan Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 143 Japan Respiratory Syncytical Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 144 Japan Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 145 Japan Fusion Glycoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 146 Japan Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 147 Japan Geriatric In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 148 Japan Child In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 149 Japan Adult In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Asia-pacific Antiviral Drugs: Segmentation
- Figure 2 Asia-pacific Antiviral Drugs Market: Data Triangulation
- Figure 3 Asia-pacific Antiviral Drugs Market: Droc Analysis
- Figure 4 Asia-pacific Antiviral Drugs Market: Asia-pacific Vs Regional Market Analysis
- Figure 5 Asia-pacific Antiviral Drugs Market: Company Research Analysis
- Figure 6 Asia-pacific Antiviral Drugs Market: Interview Demographics
- Figure 7 Asia-pacific Antiviral Drugs Market: Dbmr Market Position Grid
- Figure 8 Asia-pacific Antiviral Drugs Market: Market Testing Type Coverage Grid
- Figure 9 Asia-pacific Antiviral Drugs Market: Vendor Share Analysis
- Figure 10 Asia-pacific Antiviral Drugs Market: Segmentation
- Figure 11 The Rising Prevalence Of Viral Infections Is Expected To Drive The Asia-pacific Antiviral Drugs Market In The Forecast Period
- Figure 12 The Influenza Segment Is Expected To Account For The Largest Share Of The Asia-pacific Antiviral Drugs Market In 2023 & 2030
- Figure 13 North America Is Expected To Dominate The Asia-pacific Antiviral Drugs Market, And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period
- Figure 14 Asia-pacific Is The Fastest-growing Market For Asia-pacific Antiviral Drugs Market Manufacturers In The Forecast Period
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Asia-pacific Antiviral Drugs Market
- Figure 16 Asia-pacific Antiviral Drugs Market: By Indication , 2022
- Figure 17 Asia-pacific Antiviral Drugs Market: By Indication , 2023-2030 (Usd Million)
- Figure 18 Asia-pacific Antiviral Drugs Market: By Indication , Cagr (2023-2030)
- Figure 19 Asia-pacific Antiviral Drugs Market: By Indication , Lifeline Curve
- Figure 20 Asia-pacific Antiviral Drugs Market: By Patient Type, 2022
- Figure 21 Asia-pacific Antiviral Drugs Market: By Patient Type, 2023-2030 (Usd Million)
- Figure 22 Asia-pacific Antiviral Drugs Market: By Patient Type, Cagr (2023-2030)
- Figure 23 Asia-pacific Antiviral Drugs Market: By Patient Type, Lifeline Curve
- Figure 24 Asia-pacific Antiviral Drugs Market: By Product, 2022
- Figure 25 Asia-pacific Antiviral Drugs Market: By Product, 2023-2030 (Usd Million)
- Figure 26 Asia-pacific Antiviral Drugs Market: By Product, Cagr (2023-2030)
- Figure 27 Asia-pacific Antiviral Drugs Market: By Product, Lifeline Curve
- Figure 28 Asia-pacific Antiviral Drugs Market: By Drug Type, 2022
- Figure 29 Asia-pacific Antiviral Drugs Market: By Drug Type, 2023-2030 (Usd Million)
- Figure 30 Asia-pacific Antiviral Drugs Market: By Drug Type, Cagr (2023-2030)
- Figure 31 Asia-pacific Antiviral Drugs Market: By Drug Type, Lifeline Curve
- Figure 32 Asia-pacific Antiviral Drugs Market: By End User, 2022
- Figure 33 Asia-pacific Antiviral Drugs Market: By End User, 2023-2030 (Usd Million)
- Figure 34 Asia-pacific Antiviral Drugs Market: By End User, Cagr (2023-2030)
- Figure 35 Asia-pacific Antiviral Drugs Market: By End User, Lifeline Curve
- Figure 36 Asia-pacific Antiviral Drugs Market: By Distribution Channel, 2022
- Figure 37 Asia-pacific Antiviral Drugs Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 38 Asia-pacific Antiviral Drugs Market: By Distribution Channel, Cagr (2023-2030)
- Figure 39 Asia-pacific Antiviral Drugs Market: By Distribution Channel, Lifeline Curve
- Figure 40 Asia-pacific Antiviral Drugs Market: Snapshot (2022)
- Figure 41 Asia-pacific Antiviral Drugs Market: By Country (2022)
- Figure 42 Asia-pacific Antiviral Drugs Market: By Country (2023 & 2030)
- Figure 43 Asia-pacific Antiviral Drugs Market: By Country (2022 & 2030)
- Figure 44 Asia-pacific Antiviral Drugs Market: Indication (2023-2030)
- Figure 45 Asia-pacific Antiviral Drugs Market: Company Share 2022 (%) 372
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook